Emerging roles of the microbiome in cancer

Carcinogenesis

Volumn 35, Issue 2, 2014, Pages 249-255

  Bultman, Scott J ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; ELLAGIC ACID; HISTONE DEACETYLASE INHIBITOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 23; PREBIOTIC AGENT; PROBIOTIC AGENT;

CANCER PREVENTION; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHEMOPROPHYLAXIS; COLON FLORA; COLORECTAL CANCER; CYTOKINE PRODUCTION; DIETARY FIBER; ENVIRONMENTAL FACTOR; EPIGENETICS; FECES MICROFLORA; GENE EXPRESSION; GENETIC ASSOCIATION; GENOMIC INSTABILITY; GNOTOBIOTICS; HUMAN; INNATE IMMUNITY; INSULIN RESISTANCE; INTESTINE FLORA; METAGENOMICS; MICROBIAL COMMUNITY; MICROBIOME; NEOPLASM; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TUMOR MICROENVIRONMENT; TUMOR PROMOTION; TUMOR VOLUME;

ANIMALS; ANTI-BACTERIAL AGENTS; GASTROINTESTINAL TRACT; HUMANS; MICE; MICROBIOTA; NEOPLASMS;

EID: 84893428147     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt392     Document Type: Review

References (110)

1. Mariotto,A.B. et al. (2011) Projections of the cost of cancer care in the United States: 2010-2020. J. Natl Cancer Inst., 103, 117-128.
2. Jemal,A. et al. (2011) Global cancer statistics. Cancer J. Clin., 61, 69-90.
3. Hanahan,D. et al. (2011) Hallmarks of cancer: the next generation. Cell, 144, 646-674.
4. Vogelstein,B. et al. (2013) Cancer genome landscapes. Science, 339, 1546-1558.
5. Anonymous (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature, 487, 330-337.
6. Weinstock,G.M. (2012) Genomic approaches to studying the human microbiota. Nature, 489, 250-256.
7. Anonymous (2012) Structure, function and diversity of the healthy human microbiome. Nature, 486, 207-214.
8. Costello,E.K. et al. (2009) Bacterial community variation in human body habitats across space and time. Science, 326, 1694-1697.
9. Ley,R.E. et al. (2006) Microbial ecology: human gut microbes associated with obesity. Nature, 444, 1022-1023.
10. Gill,S.R. et al. (2006) Metagenomic analysis of the human distal gut microbiome. Science, 312, 1355-1359.
11. Dethlefsen,L. et al. (2007) An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature, 449, 811-818.
12. Ley,R.E. et al. (2008) Evolution of mammals and their gut microbes. Science, 320, 1647-1651.
13. Arumugam,M. et al.; MetaHIT Consortium. (2011) Enterotypes of the human gut microbiome. Nature, 473, 174-180.
14. Qin,J. et al.; MetaHIT Consortium. (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature, 464, 59-65.
15. Benson,A.K. et al. (2010) Individuality in gut microbiota composition is a complex polygenic trait shaped by multiple environmental and host genetic factors. Proc. Natl Acad. Sci. USA, 107, 18933-18938.
16. Claesson, M.J. et al. (2012) Gut microbiota composition correlates with diet and health in the elderly. Nature, 488, 178-184.
17. Song,S.J. et al. (2013) Cohabiting family members share microbiota with one another and with their dogs. Elife, 2, e00458.
18. Wu,G.D. et al. (2011) Linking long-term dietary patterns with gut microbial enterotypes. Science, 334, 105-108.
19. Dethlefsen,L. et al. (2008) The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol., 6, e280.
20. van Vliet,M.J. et al. (2009) Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut. Clin. Infect. Dis., 49, 262-270.
21. Zwielehner,J. et al. (2011) Changes in human fecal microbiota due to chemotherapy analyzed by TaqMan-PCR, 454 sequencing and PCRDGGE fingerprinting. PLoS One, 6, e28654.
22. Antonopoulos,D.A. et al. (2009) Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect. Immun., 77, 2367-2375.
23. Young,V.B. et al. (2004) Antibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota. J. Clin. Microbiol., 42, 1203-1206.
24. Clemente,J.C. et al. (2012) The impact of the gut microbiota on human health: an integrative view. Cell, 148, 1258-1270.
25. Dimitrov,D.V. (2011) The human gutome: nutrigenomics of the hostmicrobiome interactions. OMICS, 15, 419-430.
26. Kinross,J.M. et al. (2011) Gut microbiome-host interactions in health and disease. Genome Med., 3, 14.
27. Iliev,I.D. et al. (2012) Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis. Science, 336, 1314-1317.
28. Turner,J.R. (2009) Intestinal mucosal barrier function in health and disease. Nat. Rev. Immunol., 9, 799-809.
29. Araújo-Pérez,F. et al. (2012) Differences in microbial signatures between rectal mucosal biopsies and rectal swabs. Gut Microbes, 3, 530-535.
30. Eckburg,P.B. et al. (2005) Diversity of the human intestinal microbial flora. Science, 308, 1635-1638.
31. Zoetendal,E.G. et al. (2002) Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl. Environ. Microbiol., 68, 3401-3407.
32. Castellarin,M. et al. (2012) Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res., 22, 299-306.
33. Kostic,A.D. et al. (2012) Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res., 22, 292-298.
34. Wostmann,B.S. (1981) The germfree animal in nutritional studies. Annu. Rev. Nutr., 1, 257-279.
35. Bäckhed,F. et al. (2004) The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl Acad. Sci. USA, 101, 15718-15723.
36. Cho,I. et al. (2012) Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature, 488, 621-626.
37. Kamada,N. et al. (2013) Role of the gut microbiota in immunity and inflammatory disease. Nat. Rev. Immunol., 13, 321-335.
38. Sellon,R.K. et al. (1998) Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect. Immun., 66, 5224-5231.
39. Engle,S.J. et al. (2002) Elimination of colon cancer in germ-free transforming growth factor beta 1-deficient mice. Cancer Res., 62, 6362-6366.
40. Ivanov,I.I. et al. (2008) Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe, 4, 337-349.
41. Atarashi,K. et al. (2008) ATP drives lamina propria T(H)17 cell differentiation. Nature, 455, 808-812.
42. Smith,M.I. et al. (2013) Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science, 339, 548-554.
43. Turnbaugh,P.J. et al. (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature, 444, 1027-1031.
44. Ridaura,V.K. et al. (2013) Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science, 341, 1241214.
45. Itzkowitz,S.H. et al. (2004) Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Gastroenterology, 126, 1634-1648.
46. Cuzick,J. et al. (2009) Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. Lancet Oncol., 10, 501-507.
47. Bosetti,C. et al. (2006) Aspirin and cancer risk: an updated quantitative review to 2005. Cancer Causes Control, 17, 871-888.
48. Arthur,J.C. et al. (2012) Intestinal inflammation targets cancer-inducing activity of the microbiota. Science, 338, 120-123.
49. Mangerich,A. et al. (2012) Infection-induced colitis in mice causes dynamic and tissue-specific changes in stress response and DNA damage leading to colon cancer. Proc. Natl Acad. Sci. USA, 109, E1820-E1829.
50. Rooks,M.G. et al. (2011) Bacteria, food, and cancer. F1000 Biol. Rep., 3, 12.
51. Willett,W.C. (2005) Diet and cancer: an evolving picture. JAMA, 293, 233-234.
52. Huycke,M.M. et al. (2004) Commensal bacteria, redox stress, and colorectal cancer: mechanisms and models. Exp. Biol. Med. (Maywood)., 229, 586-597.
53. Calle,E.E. et al. (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat. Rev. Cancer, 4, 579-591.
54. Khandekar,M.J. et al. (2011) Molecular mechanisms of cancer development in obesity. Nat. Rev. Cancer, 11, 886-895.
55. Yoshimoto,S. et al. (2013) Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature, 499, 97-101.
56. Dapito,D.H. et al. (2012) Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell, 21, 504-516.
57. Vijay-Kumar,M. et al. (2010) Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science, 328, 228-231.
58. Round,J.L. et al. (2011) The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science, 332, 974-977.
59. Kostic,A.D. et al. (2013) Exploring host-microbiota interactions in animal models and humans. Genes Dev., 27, 701-718.
60. Ubeda,C. et al. (2012) Familial transmission rather than defective innate immunity shapes the distinct intestinal microbiota of TLR-deficient mice. J. Exp. Med., 209, 1445-1456.
61. Grivennikov,S.I. et al. (2012) Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature, 491, 254-258.
62. Huber,S. et al. (2012) IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine. Nature, 491, 259-263.
63. Winter,S.E. et al. (2013) Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science, 339, 708-711.
64. Blaser,M. (2011) Antibiotic overuse: stop the killing of beneficial bacteria. Nature, 476, 393-394.
65. Lawley,T.D. et al. (2012) Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog., 8, e1002995.
66. Guarner,F. et al. (2003) Gut flora in health and disease. Lancet, 361, 512-519.
67. Kolars,J.C. et al. (1984) Yogurt-an autodigesting source of lactose. N. Engl. J. Med., 310, 1-3.
68. de Vrese,M. et al. (2001) Probiotics-compensation for lactase insufficiency. Am. J. Clin. Nutr., 73 (suppl. 2), 421S-429S.
69. Khazaie,K. et al. (2012) Abating colon cancer polyposis by Lactobacillus acidophilus deficient in lipoteichoic acid. Proc. Natl Acad. Sci. USA, 109, 10462-10467.
70. Motta,J.P. et al. (2012) Food-grade bacteria expressing elafin protect against inflammation and restore colon homeostasis. Sci. Transl. Med., 4, 158ra144.
71. Carroll,I.M. et al. (2007) Anti-inflammatory properties of Lactobacillus gasseri expressing manganese superoxide dismutase using the interleukin 10-deficient mouse model of colitis. Am. J. Physiol. Gastrointest. Liver Physiol., 293, G729-G738.
72. Davis,C.D. et al. (2009) Gastrointestinal microflora, food components and colon cancer prevention. J. Nutr. Biochem., 20, 743-752.
73. Larrosa,M. et al. (2006) Urolithins, ellagic acid-derived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activities. J. Agric. Food Chem., 54, 1611-1620.
74. González-Sarrías,A. et al. (2010) NF-kappaB-dependent anti-inflammatory activity of urolithins, gut microbiota ellagic acid-derived metabolites, in human colonic fibroblasts. Br. J. Nutr., 104, 503-512.
75. Atkinson,C. et al. (2005) Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp. Biol. Med. (Maywood)., 230, 155-170.
76. Bolca,S. et al. (2007) Microbial and dietary factors are associated with the equol producer phenotype in healthy postmenopausal women. J. Nutr., 137, 2242-2246.
77. Lampe,J.W. (2010) Emerging research on equol and cancer. J. Nutr., 140, 1369S-1372S.
78. Lim,C.C. et al. (2005) Dietary fibres as "prebiotics": implications for colorectal cancer. Mol. Nutr. Food Res., 49, 609-619.
79. Roediger,W.E. (1980) Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut, 21, 793-798.
80. Roediger,W.E. (1982) Utilization of nutrients by isolated epithelial cells of the rat colon. Gastroenterology, 83, 424-429.
81. Donohoe,D.R. et al. (2011) The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab., 13, 517-526.
82. Donohoe,D.R. et al. (2012) Microbial regulation of glucose metabolism and cell-cycle progression in mammalian colonocytes. PLoS One, 7, e46589.
83. Balamurugan,R. et al. (2008) Real-time polymerase chain reaction quantification of specific butyrate-producing bacteria, Desulfovibrio and Enterococcus faecalis in the feces of patients with colorectal cancer. J. Gastroenterol. Hepatol., 23(8 Pt 1), 1298-1303.
84. Wang,T. et al. (2012) Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J., 6, 320-329.
85. Weir,T.L. et al. (2013) Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS One, 8, e70803.
86. Wu,N. et al. (2013) Dysbiosis signature of fecal microbiota in colorectal cancer patients. Microb. Ecol., 66, 462-470.
87. Ou,J. et al. (2013) Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans. Am. J. Clin. Nutr., 98, 111-120.
88. Lupton,J.R. (2004) Microbial degradation products influence colon cancer risk: the butyrate controversy. J. Nutr., 134, 479-482.
89. Donohoe,D.R. et al. (2012) The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. Mol. Cell, 48, 612-626.
90. Davie,J.R. (2003) Inhibition of histone deacetylase activity by butyrate. J. Nutr., 133(suppl. 7), 2485S-2493S.
91. Hamer,H.M. et al. (2008) Review article: the role of butyrate on colonic function. Aliment. Pharmacol. Ther., 27, 104-119.
92. Smith,P.M. et al. (2013) The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science, 341, 569-573.
93. Nicholson,J.K. et al. (2012) Host-gut microbiota metabolic interactions. Science, 336, 1262-1267.
94. Plottel,C.S. et al. (2011) Microbiome and malignancy. Cell Host Microbe, 10, 324-335.
95. Wallace,B.D. et al. (2010) Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science, 330, 831-835.
96. Haiser,H.J. et al. (2012) Is it time for a metagenomic basis of therapeutics? Science, 336, 1253-1255.
97. Nicholson,J.K. et al. (2005) Gut microorganisms, mammalian metabolism and personalized health care. Nat. Rev. Microbiol., 3, 431-438.
98. Haiser,H.J. et al. (2013) Predicting and manipulating cardiac drug inactivation by the human gut bacterium Eggerthella lenta. Science, 341, 295-298.
99. Turnbaugh,P.J. et al. (2010) Organismal, genetic, and transcriptional variation in the deeply sequenced gut microbiomes of identical twins. Proc. Natl Acad. Sci. USA, 107, 7503-7508.
100. Mager,D.L. et al. (2005) The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects. J. Transl. Med., 3, 27.
101. Khan,A.A. et al. (2012) Normal to cancer microbiome transformation and its implication in cancer diagnosis. Biochim. Biophys. Acta, 1826, 331-337.
102. Gong,H.L. et al. (2013) The composition of microbiome in larynx and the throat biodiversity between laryngeal squamous cell carcinoma patients and control population. PLoS One, 8, e66476.
103. Narikiyo,M. et al. (2004) Frequent and preferential infection of Treponema denticola, Streptococcus mitis, and Streptococcus anginosus in esophageal cancers. Cancer Sci., 95, 569-574.
104. Macfarlane,S. et al. (2007) Microbial colonization of the upper gastrointestinal tract in patients with Barrett's esophagus. Clin. Infect. Dis., 45, 29-38.
105. Anderson,L.A. et al. (2008) Relationship between Helicobacter pylori infection and gastric atrophy and the stages of the oesophageal inflammation, metaplasia, adenocarcinoma sequence: results from the FINBAR case-control study. Gut, 57, 734-739.
106. Farrell,J.J. et al. (2012) Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer. Gut, 61, 582-588.
107. Sharma,V. et al. (2007) Role of bile bacteria in gallbladder carcinoma. Hepatogastroenterology, 54, 1622-1625.
108. Kim,N.H. et al. (2002) Purulent pericarditis caused by group G streptococcus as an initial presentation of colon cancer. J. Korean Med. Sci., 17, 571-573.
109. Kanazawa,K. et al. (1996) Factors influencing the development of sigmoid colon cancer. Bacteriologic and biochemical studies. Cancer, 77(suppl. 8), 1701-1706.
110. Scanlan,P.D. et al. (2008) Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis. Environ. Microbiol., 10, 789-798.